In January 2024, I spoke with Lloyd Sederer, MD, a psychiatrist and public health expert, the day after his newest book came out. The book is Caught in the Crosshairs of American Healthcare, and it argues that for-profit corporations have taken control of medical care in the United States, to the great detriment of the people who depend on it.
In November 2023, I spoke with Lorraine Nilon, an author from Australia who describes herself as a soul intuitive. She works mostly with people recovering from childhood abuse and narcissistic relationships, and many of them have also lived through alcohol or drug dependence.
In October 2023, I spoke with Ladan Eshkevari, PhD, a physiologist and nurse anesthetist who taught anesthetic drugs to graduate students at Georgetown University for many years. She now leads Avesta Ketamine and Wellness, which has clinics in the Washington, D.C.
In September 2023, I spoke with Michael Eon, author of These Things Happen, a novel that was about to be released on the 19th of that month. At 0:19, I told him I loved it.
In August 2023, I spoke with Dr. Steven Reichbach, an anesthesiologist who has worked with ketamine for about three decades. His clinic gives ketamine by intravenous infusion to people with certain mood disorders and certain chronic nerve pain conditions.
In June 2023, I spoke again with Lewis Nelson, MD, the chair of emergency medicine at Rutgers New Jersey Medical School.
In June 2023, I spoke with David Kenney and Susan Kenney of Emergo Academy, which trains and certifies recovery coaches. Their method, which they call Actualized Recovery, starts with the brain and the body before it turns to thoughts and habits.
In June 2023, I spoke with Dustin Swartz, who went through dozens of treatment centers and detoxes before his life changed. Since then, he has joined Guy Sengstock's group of circling practitioners and coaches and become part of a healing community called Fit for Service.
In June 2023, I spoke with Nicole Lamberson, who survived a cold turkey stop from several psychiatric medications and has lived with protracted withdrawal for years. She now works with the documentary Medicating Normal and advocates for people injured by prescribed medications.
In May 2023, I spoke with Chad Harman, the chief executive officer (CEO) of Psycheceutical. At 0:17, he described it as a bioscience company focused on mental health treatments, with psychedelic medicines as its lead compounds.
In April 2023, I spoke with Eudania Burrell, who goes by Dana. She is a federal agent with the Department of Homeland Security, a real estate investor, and a coach, and she has been in recovery from alcohol and drug use since 1998.
In April 2023, I spoke with Milly Day for the second time. When she first came on the show, she was helping to lead walking treks for people in recovery.